Clinical Trials in Salt Lake City

Showing 2701-2720 of 14,325 trials

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

NCT05244304

The primary objective of this trial is to assesses the efficacy of tinlarebant in slowing the rate of growth of atrophic lesion(s) in adolescent subjects with STGD1

Stargardt Disease 1

Belite Bio, Inc104 participantsStarted Mar 2022

Palo Alto, California, United States • Minneapolis, Minnesota, United States • Salt Lake City, Utah, United States +16 more locations

RECRUITINGNA< 1 mile

Combining a Smartphone App With Medications to Manage Heavy Drinking

NCT06303778

One in 10 Veterans have an alcohol use disorder. However, few Veterans receive evidenced-based psychosocial interventions or medications to treat alcohol use disorder. Barriers to receiving these treatments include long wait times, stigma, and long distances from treatment facilities. Even fewer Veterans receive psychosocial and medication interventions together, despite clinical practice guidelines recommending both and evidence of better outcomes. Expanding access to these treatments in primary care is a VA priority but delivering psychosocial interventions is difficult in this setting, and medication is often the only option. Smartphone apps that deliver alcohol interventions may improve drinking outcomes and ensure Veterans can receive both treatments in primary care. This study will determine whether medications and an app for alcohol use problems offered to Veterans in primary care results in improved drinking outcomes, compared to Veterans receiving medications only. Study data will inform how to spread the app across the VA nationally.

Alcohol Use Disorder (AUD)

VA Office of Research and Development330 participantsStarted Nov 2024

Phoenix, Arizona, United States • Fayetteville, Arkansas, United States • Washington D.C., District of Columbia, United States +12 more locations

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Combining a Smartphone App With Medications to Manage Heavy Drinking

Find Trials by Condition in Salt Lake City

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Ca-Mg Butyrate in GWI

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

ZILRETTA in Subjects With Shoulder Osteoarthritis

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Post-Market Study to Assess iTind Safety in Comparison to UroLift

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Open-label Extension of the HOPE-2 Trial

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

FebriDx® Pediatric Validation Study

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial